Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7

被引:37
|
作者
Liu, Lei [1 ]
Zhao, Xiaokun [1 ]
Zhu, Xuan [1 ]
Zhong, Zhaohui [1 ]
Xu, Ran [1 ]
Wang, Zijian [1 ]
Cao, Jian [1 ]
Hou, Yi [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China
关键词
bladder cancer; microRNA-430; CXCR7; MATRIX METALLOPROTEINASES; MICRORNAS; CELLS;
D O I
10.3892/mmr.2013.1477
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) have been demonstrated to be involved in the development of numerous types of malignant tumor. However, the role of miRNA-430 (miR-430) in bladder cancer remains unclear. In the present study, we observed that the expression of miR-430 was significantly downregulated in bladder cancer. Furthermore, the overexpression of miR-430 in human bladder cancer 5637 cells significantly inhibited cell proliferation, migration and colony formation efficiency. These findings were contrary to those obtained following the overexpression of CXCR7, which was found to be a direct target of miR-430 in this study. Further analysis showed that cell proliferation- and migration-related genes, including ERK, matrix metalloproteinase-2 (MMP-2) and MMP-9, were significantly downregulated in miR-430 overexpressed 5637 cells, while they were markedly upregulated in CXCR7 overexpressed 5637 cells. In conclusion, our study reveals important roles of miR-430 and CXCR7 in bladder cancer, and suggests that the downregulation of miR-430 enhances the development of bladder cancer, partly via the upregulation of CXCR7.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 50 条
  • [1] miR-430和CXCR7在前列腺癌中的表达
    黄国华
    唐贤富
    唐超来
    中国临床研究, 2018, 31 (04) : 463 - 466
  • [2] CXCR7 expression in esophageal cancer
    Michael Tachezy
    Hilke Zander
    Florian Gebauer
    Katharina von Loga
    Klaus Pantel
    Jakob R Izbicki
    Maximilian Bockhorn
    Journal of Translational Medicine, 11
  • [3] CXCR7 expression in esophageal cancer
    Tachezy, Michael
    Zander, Hilke
    Gebauer, Florian
    von Loga, Katharina
    Pantel, Klaus
    Izbicki, Jakob R.
    Bockhorn, Maximilian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [4] Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer
    Yang, Jihua
    Tang, Hao
    Huang, Jingyu
    An, Huaijie
    MEDICAL SCIENCE MONITOR, 2018, 24 : 5185 - 5191
  • [5] CHEMOKINE RECEPTOR CXCR7 IS A MOLECULAR DETERMINANT OF BLADDER CANCER
    Gosalbez, Miguel
    Knapp, Judith
    Gomez, Christopher
    Lokeshwar, Soum
    Kramer, Mario
    Besharat, Kaveh
    Stenzl, Arnulf
    Soloiway, Mark S.
    Lokeshwar, Bal
    Lokeshwar, Vinata
    JOURNAL OF UROLOGY, 2009, 181 (04): : 303 - 303
  • [6] Role of chemokine receptor CXCR7 in bladder cancer progression
    Hao, Mingang
    Zheng, Jianghua
    Hou, Kailin
    Wang, Jinglong
    Chen, Xiaosong
    Lu, Xiaojiong
    Bo, Junjie
    Xu, Chen
    Shen, Kunwei
    Wang, Jianhua
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (02) : 204 - 214
  • [7] CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
    Siran Xu
    Jiaze Tang
    Chunying Wang
    Jie Liu
    Yan Fu
    Yongzhang Luo
    Cell Death & Disease, 10
  • [8] CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
    Xu, Siran
    Tang, Jiaze
    Wang, Chunying
    Liu, Jie
    Fu, Yan
    Luo, Yongzhang
    CELL DEATH & DISEASE, 2019, 10 (3)
  • [9] Chemokine receptor CXCR4 but not CXCR7 promotes drug resistance in cancer via death receptor downregulation
    Maheshwari, S.
    Nengroo, M. A.
    Singh, A.
    Chaturvedi, P.
    Verma, A.
    Datta, D.
    CANCER MEDICINE, 2018, 7 : 40 - 40
  • [10] Increased expression of CXCR7 is associated with gastric cancer progression
    Shi, Ameng
    Dong, Lei
    Shi, Haitao
    Jiang, Jiong
    Guo, Xiaoyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 220 - 220